UK cannabis medicine trial limited to 150 prescriptions

A small number of patients are to be given cannabis medicine prescriptions as part of a UK trial to test their effectiveness. GW Pharmaceuticals have offered an early access programme and made available 150 prescriptions, 125 for children and 25 for adults. That means, for example, that Dr Chris Rittey, a consultant pediatric neurologist at […]

Continue Reading

Raphael Mechoulam joins GW Pharma hoping for a “fruitful collaboration”

The “godfather” of cannabis science is teaming up with the UK cannabis giant GW Pharmaceuticals, the world’s largest exporter of medicinal cannabis. In amongst the mass of news pouring out from North America as they steam ahead with recreational legalistion, the pharmaceutical powerhouse GW Pharmaceuticals has largely been left unchallenged in the UK despite rumours […]

Continue Reading

This Week In Weed – 4 November 2018

Supply shortage in Canada deepens Demand continues to outstrip supply two weeks after Canada became the first G20 country to legalise cannabis. Rosalie Wyonch, a policy analyst at the CD Howe Institute, said the problem has developed “faster than I would have expected”. When Colorado legalised recreational cannabis, it took some three years for supply […]

Continue Reading

GPs will NOT be able to prescribe Medicinal Cannabis in the UK

Medicinal Cannabis Defined: UK Home Office sets out rules for products On 21 September, the Government formally announced its definition of what qualifies as ‘cannabis-based’ products for medicinal use ahead of a proposed law change this autumn, including in Northern Ireland. But it said that only doctors on the Specialist Register of the General Medical […]

Continue Reading